Dr. Boisen’s work has focused primarily on women with gynecologic malgnancies and particularly on women with ovarian cancer. Her laboratory work has involved collaboration with Dr. Steffi Oesterreich in characterizing signatures of estrogen receptor signaling in both high grade serous and endometriosis-associated ovarian cancers. Clinically, Dr. Boisen has an interest in evaluating therapeutic strategies for ovarian cancer and has published in the area of intraperitoneal chemotherapy and HIPEC. Currently she is working with several other division members looking at the outcomes of patients treated with neoadjuvant chemotherapy. Dr. Boisen is also interested improving post-operative outcomes and is working in conjunction with others in the division and within the healthcare system to implement an enhanced surgical recovery pathway.
